Prof Martin Vordermeier | Team Leader
Animal Health and Veterinary Laboratories Agency

Prof Martin Vordermeier, Team Leader, Animal Health and Veterinary Laboratories Agency

He is a cellular immunologist with 23 years’ experience of mycobacterial research both in the human (MRC TB and Related Infections Unit, Hammersmith Hospital, London from 1990 – 1997) and bovine tuberculosis fields. Since 1997 he ha been leading a team at APHA investigating the immune responses in cattle to Mycobacterium bovis infection, the development of vaccines and immuno-diagnostic reagents including the definition of molecular biomarkers correlating with protection and disease, the transmission and pathogenesis of this disease in cattle. Martin has authored to-date around 250 publications on this and related subjects. He is the principal applicant or co-applicant on Defra, Wellcome Trust, EMIDA, BMGF Foundation, BBSRC and EU funded projects. Martin is or has been a member of the editorial boards of Infection and Immunity (2004-09), Clinical Vaccine Immunology (2008-2013), Veterinary Immunology and Immunopathology and other scientific journals, as well served recently as guest editor of Research in Veterinary Science. He is also the visiting professor at the University of Surrey. Since 2010, and a Jenner Investigator.


Day 3 Oct 12th Veterinary @ 11:20

Application of DIVA vaccines to address Bovine Tuberculosis in Cattle

  • Discussing progress made on optimizing the only potentially available vaccine, bacille Calmette Guérin (BCG)
  • What strategies are there to improve BCG efficacy?
  • Highlighting recent advances in DIVA development based on the detection of host cellular immune responses by blood-testing or skin-testing approaches
  • What are the next steps necessary in order to accelerate DIVA vaccine development?

back to speakers